NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE266239 Query DataSets for GSE266239
Status Public on May 03, 2024
Title Single Cell Sequencing of Human Langerhans Cells Identifies Altered Gene Expression Profiles in Patients with Atopic Dermatitis
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Atopic dermatitis (AD) is characterized by dysregulated T cell immunity and skin microbiome dysbiosis with predominance of Staphylococcus aureus (S. aureus). Emerging evidence suggests a role for S. aureus in exacerbating AD skin inflammation. Interestingly, specific glycosylation of S. aureus cell wall structures amplifies skin inflammation through interaction with Langerhans cells (LCs). However, the role of LCs in AD remains poorly characterized. Here, we performed single cell RNA-sequencing of primary epidermal LCs and dermal T cells isolated from skin biopsies of AD patients and healthy controls, alongside specific glycoanalysis of S. aureus strains isolated from the AD lesions. Our findings reveal four LC subpopulations, including two steady-state clusters (LC1 and LC1H) and two pro-inflammatory/matured subsets (LC2 and migratory LCs). The latter two subsets were enriched in AD skin. AD LCs showed enhanced expression of C-type lectin receptors, the high-affinity IgE receptor (FcεR1), and activation of prostaglandin and leukotrienes biosynthesis pathways, as well as upregulated transcriptional signatures related to T cell activation pathways and increased expression of CCL17 (specifically LC2) compared to healthy LCs. Correspondingly, T helper 2 and regulatory T cell populations were increased in AD lesions. Our study provides proof-of-concept for an active role of LCs in connecting the S. aureus-T cell axis in the AD inflammatory cycle.
 
Overall design Single cell RNA sequencing (sort-seq) of human epidermal Langerhans cells and dermal T cells from atopic dermatitis patients (n=4 for LCs n=3 for T cells) and healthy controls (n=3)
 
Contributor(s) Tamminga SM, van der Wal MM, van Wijk F, van Sorge NM
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Apr 30, 2024
Last update date May 04, 2024
Contact name Nina van Sorge
Organization name Amsterdam UMC
Street address Meibergdreef 9
City Amsterdam
ZIP/Postal code 1105AZ
Country Netherlands
 
Platforms (1)
GPL18573 Illumina NextSeq 500 (Homo sapiens)
Samples (13)
GSM8242943 LC_HC02
GSM8242944 LC_HC03
GSM8242945 LC_HC01
Relations
BioProject PRJNA1106436

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE266239_RAW.tar 20.0 Mb (http)(custom) TAR (of TSV)
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap